Benjamin England, 17-year FDA Veteran, Former FDA Regulatory Counsel to Speak at The Global Knowledge Congress’ Upcoming FDA Regulations in Food Label Teleconference
Benjamin England, 17-year FDA Veteran, Former FDA Regulatory Counsel, and Partner at Leading Law Firm Rodriguez, O'Donnell, Ross, Fuerst, Gonzalez, Williams & England, P.C., to Speak at The Global Knowledge Congress’ Upcoming FDA Regulations in Food Label Teleconference
New York, NY, May 05, 2006 --(PR.com)-- The Global Knowledge Congress, the leading producer of regulatory focused teleconferences, has announced today that Benjamin England, 17-year FDA Veteran, Former FDA Regulatory Counsel, and Partner at Leading Law Firm Rodriguez, O'Donnell, Ross, Fuerst, Gonzalez, Williams & England, P.C., to Speak at The Global Knowledge Congress’ Upcoming FDA Regulations in Food Label Teleconference scheduled tentatively for May 23, 2006 at 11:00 AM EST.
Recently, the FDA has changed many of the rules governing how food is labeled for consumer products. Changes include: listing the amount of trans fat, notification of eight allergen groups, and a new definition of "whole grain". The Global Knowledge Congress has assembled a team of experts to help analyze these changes and their impact on the companies servicing this industry. These experts will present their findings, which include a "best practice" panel at a comprehensive two-hour teleconference scheduled for May 2006.
About Benjamin England
Benjamin England is a partner at Rodriguez, O'Donnell, Ross, Fuerst, Gonzalez, Williams & England, P.C. A 17-year veteran of the U.S. Food and Drug Administration (FDA), Mr. England focuses his practice on FDA matters, including inspections; FDA and U.S. Bureau of Customs and Border Protection (Customs) import processes; criminal, regulatory and administrative actions; risk management with special knowledge related to importing FDA regulated products, regulation and agency guidance development; challenging FDA import alerts; Customs civil actions and liquidated damages claims related to FDA imported products; export certification for medical devices, drugs, and foods; and all issues related to the development, interpretation, and implementation of FDA's new bioterrorism rules and initiatives.
Mr. England's FDA experience ranges from guiding responses to FDA and U.S. Department of Agriculture (USDA) compliance actions to implementing and leveraging for clients FDA's risk-based security guidance for the food and cosmetics industries. He has overseen crossover applications of FDA's security guidance for the drug, medical device and biologics industries and participated in the development of the bioterrorism regulations affecting domestic and foreign establishments, and the agency's implementing guidance. He also has handled complex matters involving imported products subject to FDA administrative or Customs' civil enforcement (seizure, monetary penalties, or claims for liquidated damages) and criminal investigations related to drug diversion, drug counterfeiting, and smuggling.
During Mr. England’s last three years at FDA he served as Regulatory Counsel to the Associate Commissioner for Regulatory Affairs. Before this, he served in scientific, inspectional, compliance, and criminal and civil enforcement capacities as an FDA consumer safety and compliance officer, a senior special agent with the Office of Criminal Investigations and an analytical regulatory microbiologist. Most notably, during his last three years at FDA he spearheaded the agency's integration efforts with Customs on crosscutting interagency enforcement and operational issues; served as the FDA's point-person in managing the intersection of imports and FDA's new bioterrorism regulations; established joint agency and industry working groups to evaluate counterfeiting and tampering risks to food and drug distribution supply chains; was the agency lead in its strategic planning efforts to reinvent the FDA's import programs; and directed the development of the FDA's Import Strategic Plan, publicly highlighted by senior FDA officials, including former commissioner Dr. Mark McClellan and acting commissioner Lester Crawford.
Mr. England received his B.A. in biological sciences from the University of Maryland. He received his J.D., summa cum laude, from the University of Miami School of Law where he was a member of the Order of the Coif and the University of Miami Law Review.
Mr. England is a member of the Bars of Florida, Maryland, and the District of Columbia. He is also a member of the Association of Food and Drug Officials.
About Rodriguez, O'Donnell, Ross, Fuerst, Gonzalez, Williams & England, P.C
Rodriguez O’Donnell Ross Fuerst Gonzalez Williams & England, P.C. brings together specialists in the fields of international transportation and maritime law, food & drug law, Customs and international trade law, investment, tax and tax litigation, commercial transactions, and congressional activities and government relations. The firm manages for their clients the regulatory and legal risks associated with the intersections of Customs and trade, transportation, tax, and regulatory federal and state agencies.
With offices in Washington, D.C., Chicago, Miami, Los Angeles, and New York City, the firm represents both foreign and domestic clients before the governmental and international agencies that regulate and influence international commerce. The firm also represents clients in these matters in the Federal and State courts.
The firm’s attorneys are experienced professionals with an average of over twenty years of legal experience, representing clients in the highly complex and specialized areas of law governing international trade and transportation matters. Clients benefit from their familiarity and experience with the various governmental agencies that regulate the international business activities. In addition to serving as advocates of their clients’ interests before the Congress, they actively represent their clients in matters before executive branch agencies.
They are recognized for delivering timely, practical, cost-effective advice and counsel. Their broad experience and concentration in these areas means that they are already familiar with the issues and problems their clients commonly encounter. This enables them to quickly gather and assimilate relevant facts and render superior, creative legal advice. This is complemented by the extensive research files and library of materials they have compiled during years of practice and use of the latest research technologies. The firm seeks long-term relationships with its clients. They believe it is important for them to know their clients' products and objectives to maximize the value of the firm’s services.
For more information about Benjamin England and his firm, please visit: http://www.rofgw.com
About The Global Knowledge Congress
The Global Knowledge Congress is an organization that produces teleconferences that examine regulatory changes across a variety of industries. “We bring together the world's leading authorities and industry participants through informative two-hour teleconferences to study the impact of changing regulations.” To contact, please visit: http://www.knowledgecongress.org
###
Recently, the FDA has changed many of the rules governing how food is labeled for consumer products. Changes include: listing the amount of trans fat, notification of eight allergen groups, and a new definition of "whole grain". The Global Knowledge Congress has assembled a team of experts to help analyze these changes and their impact on the companies servicing this industry. These experts will present their findings, which include a "best practice" panel at a comprehensive two-hour teleconference scheduled for May 2006.
About Benjamin England
Benjamin England is a partner at Rodriguez, O'Donnell, Ross, Fuerst, Gonzalez, Williams & England, P.C. A 17-year veteran of the U.S. Food and Drug Administration (FDA), Mr. England focuses his practice on FDA matters, including inspections; FDA and U.S. Bureau of Customs and Border Protection (Customs) import processes; criminal, regulatory and administrative actions; risk management with special knowledge related to importing FDA regulated products, regulation and agency guidance development; challenging FDA import alerts; Customs civil actions and liquidated damages claims related to FDA imported products; export certification for medical devices, drugs, and foods; and all issues related to the development, interpretation, and implementation of FDA's new bioterrorism rules and initiatives.
Mr. England's FDA experience ranges from guiding responses to FDA and U.S. Department of Agriculture (USDA) compliance actions to implementing and leveraging for clients FDA's risk-based security guidance for the food and cosmetics industries. He has overseen crossover applications of FDA's security guidance for the drug, medical device and biologics industries and participated in the development of the bioterrorism regulations affecting domestic and foreign establishments, and the agency's implementing guidance. He also has handled complex matters involving imported products subject to FDA administrative or Customs' civil enforcement (seizure, monetary penalties, or claims for liquidated damages) and criminal investigations related to drug diversion, drug counterfeiting, and smuggling.
During Mr. England’s last three years at FDA he served as Regulatory Counsel to the Associate Commissioner for Regulatory Affairs. Before this, he served in scientific, inspectional, compliance, and criminal and civil enforcement capacities as an FDA consumer safety and compliance officer, a senior special agent with the Office of Criminal Investigations and an analytical regulatory microbiologist. Most notably, during his last three years at FDA he spearheaded the agency's integration efforts with Customs on crosscutting interagency enforcement and operational issues; served as the FDA's point-person in managing the intersection of imports and FDA's new bioterrorism regulations; established joint agency and industry working groups to evaluate counterfeiting and tampering risks to food and drug distribution supply chains; was the agency lead in its strategic planning efforts to reinvent the FDA's import programs; and directed the development of the FDA's Import Strategic Plan, publicly highlighted by senior FDA officials, including former commissioner Dr. Mark McClellan and acting commissioner Lester Crawford.
Mr. England received his B.A. in biological sciences from the University of Maryland. He received his J.D., summa cum laude, from the University of Miami School of Law where he was a member of the Order of the Coif and the University of Miami Law Review.
Mr. England is a member of the Bars of Florida, Maryland, and the District of Columbia. He is also a member of the Association of Food and Drug Officials.
About Rodriguez, O'Donnell, Ross, Fuerst, Gonzalez, Williams & England, P.C
Rodriguez O’Donnell Ross Fuerst Gonzalez Williams & England, P.C. brings together specialists in the fields of international transportation and maritime law, food & drug law, Customs and international trade law, investment, tax and tax litigation, commercial transactions, and congressional activities and government relations. The firm manages for their clients the regulatory and legal risks associated with the intersections of Customs and trade, transportation, tax, and regulatory federal and state agencies.
With offices in Washington, D.C., Chicago, Miami, Los Angeles, and New York City, the firm represents both foreign and domestic clients before the governmental and international agencies that regulate and influence international commerce. The firm also represents clients in these matters in the Federal and State courts.
The firm’s attorneys are experienced professionals with an average of over twenty years of legal experience, representing clients in the highly complex and specialized areas of law governing international trade and transportation matters. Clients benefit from their familiarity and experience with the various governmental agencies that regulate the international business activities. In addition to serving as advocates of their clients’ interests before the Congress, they actively represent their clients in matters before executive branch agencies.
They are recognized for delivering timely, practical, cost-effective advice and counsel. Their broad experience and concentration in these areas means that they are already familiar with the issues and problems their clients commonly encounter. This enables them to quickly gather and assimilate relevant facts and render superior, creative legal advice. This is complemented by the extensive research files and library of materials they have compiled during years of practice and use of the latest research technologies. The firm seeks long-term relationships with its clients. They believe it is important for them to know their clients' products and objectives to maximize the value of the firm’s services.
For more information about Benjamin England and his firm, please visit: http://www.rofgw.com
About The Global Knowledge Congress
The Global Knowledge Congress is an organization that produces teleconferences that examine regulatory changes across a variety of industries. “We bring together the world's leading authorities and industry participants through informative two-hour teleconferences to study the impact of changing regulations.” To contact, please visit: http://www.knowledgecongress.org
###
Contact
The Global Knowledge Congress
Thomas LaPointe, Jr., Executive Director
646-202-9344
www.knowledgecongress.org
Therese Lumbao, Member Services Director
tlumbao@knowledgecongress.org
Thomas LaPointe, Jr., Executive Director
646-202-9344
www.knowledgecongress.org
Therese Lumbao, Member Services Director
tlumbao@knowledgecongress.org
Contact
Categories